BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 20, 2007
View Archived Issues
Celgene's $2.9B For Pharmion Nets Hematology, Cancer Lines
Celgene Corp. is acquiring Pharmion Corp. for $2.9 billion in a cash and stock deal that will expand the Summit, N.J.-based biotech's presence in the global hematology and oncology markets. (BioWorld Today)
Read More
No Surprise As Onyx's Nexavar Wins Approval In Liver Cancer
Read More
Speedel, Novartis In Dispute On Flow Of Aliskiren Data
Read More
Clinic Roundup
Read More
Other News To Note
Read More
Financings Roundup
Read More
